Chennai: People whose immune systems mount an unusually aggressive early response to tuberculosis may be less likely to respond well to standard drug .
18don MSN
Rallybio shares successful early-stage results for rare disease drug; new trial set for late 2026
Rallybio Corporation RLYB on Tuesday shared results from its Phase 1 confirmatory pharmacokinetic/pharmacodynamic (PK/PD) clinical trial of RLYB116 for complement-mediated diseases, with its initial ...
New research shows gut microbiota can metabolise peanut allergens and reduce IgE-mediated anaphylaxis severity. Learn more.
Researchers at King's College London have discovered that an immune protein best known for protecting the body against ...
Panama City, FL - March 05, 2026 - PRESSADVANTAGE - Bay Clinic of Chiropractic has expanded its comprehensive treatment ...
Stanford researchers develop breakthrough nasal spray vaccine that could potentially protect against a variety of infections, ...
Chimeric antigen receptor T (CAR-T) cell therapy has emerged as a transformative approach in modern medicine, demonstrating remarkable efficacy in targeting pathogenic B-cell lineages with ...
Elderberry tea is made from dried elderberries and is rich in antioxidants with anti-inflammatory properties. Some research suggests it may help reduce the severity of colds, flu, and other ...
Explore how proteomics enhances infectious disease detection, pathogen identification, and host response profiling in ...
Zenapet, a pet wellness company focused on nutritional support products for companion animals, is spotlighting the growing ...
TD Cowen 46th Annual Health Care Conference March 2, 2026 9:50 AM ESTCompany ParticipantsJean-Paul Kress - Chairman ...
Bursting with layers of flavor and texture, these recipes use the powers of cheese to enhance humble cruciferous veggies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results